Overview Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis Status: Recruiting Trial end date: 2023-12-01 Target enrollment: Participant gender: Summary Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis Phase: Phase 2 Details Lead Sponsor: Zydus Therapeutics Inc.